DK1347764T3 - Gelpræparat på alkoholisk basis til behandling af hypogonadisme ved transskrotal applikation - Google Patents

Gelpræparat på alkoholisk basis til behandling af hypogonadisme ved transskrotal applikation

Info

Publication number
DK1347764T3
DK1347764T3 DK01985426T DK01985426T DK1347764T3 DK 1347764 T3 DK1347764 T3 DK 1347764T3 DK 01985426 T DK01985426 T DK 01985426T DK 01985426 T DK01985426 T DK 01985426T DK 1347764 T3 DK1347764 T3 DK 1347764T3
Authority
DK
Denmark
Prior art keywords
hypogonadism
treatment
transscrotal
alcohol
application
Prior art date
Application number
DK01985426T
Other languages
English (en)
Inventor
Bernd Dr August Wolff Schulze
Eberhard Nieschlag
Original Assignee
August Wolff Gmbh & Co Kg Arzn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by August Wolff Gmbh & Co Kg Arzn filed Critical August Wolff Gmbh & Co Kg Arzn
Application granted granted Critical
Publication of DK1347764T3 publication Critical patent/DK1347764T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
DK01985426T 2000-12-22 2001-12-20 Gelpræparat på alkoholisk basis til behandling af hypogonadisme ved transskrotal applikation DK1347764T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10064205 2000-12-22
PCT/EP2001/015123 WO2002051421A2 (de) 2000-12-22 2001-12-20 Gelzusammensetzung und transskrotale applikation einer zusammensetzung zur behandlung von hypogonadismus

Publications (1)

Publication Number Publication Date
DK1347764T3 true DK1347764T3 (da) 2007-07-23

Family

ID=7668398

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01985426T DK1347764T3 (da) 2000-12-22 2001-12-20 Gelpræparat på alkoholisk basis til behandling af hypogonadisme ved transskrotal applikation

Country Status (17)

Country Link
US (2) US20040044086A1 (da)
EP (1) EP1347764B1 (da)
AT (1) ATE356626T1 (da)
CA (1) CA2432534C (da)
CY (1) CY1106595T1 (da)
CZ (1) CZ20031761A3 (da)
DE (2) DE50112206D1 (da)
DK (1) DK1347764T3 (da)
EE (1) EE05318B1 (da)
ES (1) ES2283446T3 (da)
HR (1) HRP20030510A2 (da)
HU (1) HUP0600234A3 (da)
PL (1) PL206702B1 (da)
PT (1) PT1347764E (da)
SI (1) SI1347764T1 (da)
SK (1) SK7932003A3 (da)
WO (1) WO2002051421A2 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition
BRPI0515040B1 (pt) * 2004-09-09 2021-10-13 Besins Healthcare Luxembourg S.A.R.L Géis de testosterona compreendendo propileno glicol como intensificador de penetração
EP1634583A1 (en) * 2004-09-09 2006-03-15 Laboratoires Besins International Testosterone gels comprising propylene glycol as penetration enhancer
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
SI1937276T1 (sl) 2005-10-12 2013-04-30 Unimed Pharmaceuticals, Llc C/O Abbott Laboratoires 100 Abbott Park Road Izboljšani testosteronski gel in postopek uporabe
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3860712A (en) * 1973-04-16 1975-01-14 Sterling Drug Inc Composition and method for treatment of acne or seborrhea
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4725439A (en) * 1984-06-29 1988-02-16 Alza Corporation Transdermal drug delivery device
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
DK3994A (da) * 1994-01-10 1995-07-11 Frank Nielsen CDopbevaringssystem hvor CDcoverne monteres på en skinne
EP0952833A1 (de) * 1996-05-02 1999-11-03 Azupharma GmbH Topische penile androgen-applikation zur behandlung der erektilen dysfunktion
EP0954260A1 (en) * 1996-05-22 1999-11-10 Diversified Pharmaceuticals, Inc. Compositions, methods and devices for the transdermal delivery of drugs
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
JP4139860B2 (ja) * 1997-11-10 2008-08-27 ストラカン インターナショナル リミティッド 浸透増強および刺激減少システム
DE19803193C1 (de) * 1998-01-28 1999-07-15 August Wolff Gmbh & Co Arzneim Pharmazeutische Zusammensetzung mit Lecithin und alpha-Bisabolol als Penetrationsbeschleuniger
AU2001282064B2 (en) * 2000-08-03 2007-02-01 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
ES2330188T3 (es) * 2001-12-07 2009-12-07 Besins Manufacturing Belgium Composicion farmaceutica en forma de gel o de solucion a base de dihidrotestoterona, su procedimiento de preparacion y sus utilizaciones.

Also Published As

Publication number Publication date
ATE356626T1 (de) 2007-04-15
US20100317631A1 (en) 2010-12-16
HUP0600234A2 (en) 2006-07-28
CA2432534A1 (en) 2002-07-04
EP1347764B1 (de) 2007-03-14
PT1347764E (pt) 2007-06-01
SK7932003A3 (en) 2003-11-04
CZ20031761A3 (cs) 2004-01-14
HUP0600234A3 (en) 2011-04-28
WO2002051421A2 (de) 2002-07-04
WO2002051421A3 (de) 2002-11-07
ES2283446T3 (es) 2007-11-01
US20040044086A1 (en) 2004-03-04
CY1106595T1 (el) 2012-01-25
EP1347764A2 (de) 2003-10-01
PL206702B1 (pl) 2010-09-30
DE50112206D1 (de) 2007-04-26
PL366101A1 (en) 2005-01-24
SI1347764T1 (sl) 2007-06-30
HRP20030510A2 (en) 2005-04-30
EE05318B1 (et) 2010-08-16
CA2432534C (en) 2009-09-22
DE20121209U1 (de) 2002-06-20
EE200300305A (et) 2003-12-15

Similar Documents

Publication Publication Date Title
BR0113670A (pt) Composição farmacêutica e método para tratar hipogonadismo
DK1347764T3 (da) Gelpræparat på alkoholisk basis til behandling af hypogonadisme ved transskrotal applikation
WO2002092004A3 (en) Use of hmg fragment as anti-inflammatory agents
DK1144474T3 (da) Vandig reaktiv spartelmasse
BE2015C026I2 (en) 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
DE60128673D1 (de) Verfahren zur verbesserung der grösse und des aussehens einer wunde
HK1071521A1 (en) Use of a composition comprising cis-clomiphene andtrans-clomiphene in the preparation of a medicament for increasing serum levels of testosterone
BRPI0318278B8 (pt) Compostos de éter aminocicloexílico, composição compreendendo ditos compostos, usos dos mesmos e método para modular a atividade do canal iônico em um ambiente in vitro
NI200700331A (es) Formulaciones de estrógenos conjugados y bazedoxifeno
MXPA05002489A (es) Composiciones para el cuidado personal basadas en alcohol ramificado.
CA2418167A1 (en) Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
BR0116152B1 (pt) aditivo adequado para uso como emulsificador e solubilizador, uso de um aditivo, e, composição.
GB9714274D0 (en) Pharmaceutical composition
BRPI0209619B8 (pt) agente promotor de crescimento capilar
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
MY139425A (en) Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol
DK1335930T3 (da) Fremgangsmåde til fremstilling af 3-oxo-4-azasteroider
ATE400285T1 (de) Mischungen von isoflavonen und flavonen
AR045241A1 (es) Composicion topica que comprende terbinafina e hidrocortisona
WO2004006864A3 (en) Methods and compositions for the enhancement of wound healing
DK0896532T3 (da) Acylurinstofforbindelser til behandling af coccidioidomycose i varmblodede dyr
WO2004096121A3 (en) Compositions and methods for preventing infection
DK1248636T3 (da) Dextrinholdige præparater til forebyggelse af adhæsioner
DK1173065T3 (da) Anvendelse af cellulosemikrofibriller i fermenterede mælkepræparater
DK1079836T3 (da) Anvendelse af danazol til behandling af hypogonadisme hos mænd